Barrow Hanley Mewhinney & Strauss LLC Merck & Co., Inc. Transaction History
Barrow Hanley Mewhinney & Strauss LLC
- $26.4 Billion
- Q1 2025
A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 7,791,098 shares of MRK stock, worth $627 Million. This represents 2.65% of its overall portfolio holdings.
Number of Shares
7,791,098
Previous 6,285,905
23.95%
Holding current value
$627 Million
Previous $625 Million
11.84%
% of portfolio
2.65%
Previous 2.27%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,893Shares Held
1.92BCall Options Held
17.1MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA253MShares$20.3 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.7 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.72 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.57 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.8 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $204B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...